1. Home
  2. VVOS vs DRRX Comparison

VVOS vs DRRX Comparison

Compare VVOS & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • DRRX
  • Stock Information
  • Founded
  • VVOS 2016
  • DRRX 1998
  • Country
  • VVOS United States
  • DRRX United States
  • Employees
  • VVOS N/A
  • DRRX N/A
  • Industry
  • VVOS Medical Specialities
  • DRRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • DRRX Health Care
  • Exchange
  • VVOS Nasdaq
  • DRRX Nasdaq
  • Market Cap
  • VVOS 22.9M
  • DRRX 26.3M
  • IPO Year
  • VVOS 2020
  • DRRX 2000
  • Fundamental
  • Price
  • VVOS $3.12
  • DRRX $0.80
  • Analyst Decision
  • VVOS Strong Buy
  • DRRX Buy
  • Analyst Count
  • VVOS 2
  • DRRX 2
  • Target Price
  • VVOS $6.30
  • DRRX $5.00
  • AVG Volume (30 Days)
  • VVOS 166.6K
  • DRRX 54.3K
  • Earning Date
  • VVOS 03-27-2025
  • DRRX 03-26-2025
  • Dividend Yield
  • VVOS N/A
  • DRRX N/A
  • EPS Growth
  • VVOS N/A
  • DRRX N/A
  • EPS
  • VVOS N/A
  • DRRX N/A
  • Revenue
  • VVOS $14,581,000.00
  • DRRX $8,594,000.00
  • Revenue This Year
  • VVOS $12.35
  • DRRX $54.32
  • Revenue Next Year
  • VVOS $26.02
  • DRRX N/A
  • P/E Ratio
  • VVOS N/A
  • DRRX N/A
  • Revenue Growth
  • VVOS 0.54
  • DRRX N/A
  • 52 Week Low
  • VVOS $1.91
  • DRRX $0.70
  • 52 Week High
  • VVOS $6.28
  • DRRX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 32.31
  • DRRX 49.63
  • Support Level
  • VVOS $3.75
  • DRRX $0.73
  • Resistance Level
  • VVOS $4.27
  • DRRX $0.83
  • Average True Range (ATR)
  • VVOS 0.35
  • DRRX 0.05
  • MACD
  • VVOS -0.10
  • DRRX 0.01
  • Stochastic Oscillator
  • VVOS 8.73
  • DRRX 63.57

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About DRRX DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Share on Social Networks: